EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2-positive breast cancer

Changing the standard treatment for lymphoma with bendamustine

Continuing bevacizumab with second-line chemotherapy for colorectal cancer

Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours

Bendamustine regimen more effective for lymphoma than standard CHOP

Targeting DNA damage response and repair excluding PARP for triple negative breast cancer

Molecular characterisation of breast cancer: the mutational landscape

New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer

Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer

Oncology nurses should take the lead

Impact and management of malignant wounds

Effects of metformin in pancreatic cancer with diabetes